| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fece74aa8c0cb73d997c194165159cc |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J2-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate |
2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_979a60e621c8dbafe5ca8c857670b75f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_500cecb34ccfe212d5d9773f2209b485 |
| publicationDate |
2018-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-2016560-A3 |
| titleOfInvention |
Preparation of a dosage form containing dabigatran etexilate |
| abstract |
The present invention provides a process for producing pellets with a contentndabigatran, etexilate, which does not occurnagglomeration of pellets. The pellets arenoptimally formed by a tartaric acid corenan insulating layer is applied first and then a layer is appliedncontaining dabigatran etexilate. The resulting drugnthe molds are capsules filled with pellets bearingnactive substance. A key parameter affectingnagglomeration pellets the inlet air humidity atnapplying the active ingredient to the pellet cores in a fluidized bednlayer. |
| priorityDate |
2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |